Truesight Oncology Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 1 Year 6 Months
- Last Filing with ROC 31 Mar 2024
About Truesight Oncology
Truesight Oncology Private Limited (TOPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2023 (One year and six months 5 days old ). Its registered office is in Delhi, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Aseem Gautam and Jaiti Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U86904DL2023PTC418449
-
Company No.
418449
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Aug 2023
-
Date of AGM
07 Dec 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Who are the key members and board of directors at Truesight Oncology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaiti Sharma
|
Director | 11-Aug-2023 | Current |
|
Aseem Gautam
|
Director | 11-Aug-2023 | Current |
Financial Performance of Truesight Oncology.
Enhance accessibility to Truesight Oncology's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Truesight Oncology?
Unlock access to Truesight Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Magus Consortium Orchid Avenue Private LimitedAseem Gautam is a mutual person
-
Queens Dairy Private LimitedAseem Gautam is a mutual person
-
Jyotirmay Developer Private Limited
Aseem Gautam is a mutual person
-
Magus Builders Private Limited
Aseem Gautam is a mutual person
-
Vedantam Infratech Private Limited
Aseem Gautam is a mutual person
-
Kalaagan The Future School Of Art Llp
Jaiti Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Truesight Oncology?
Unlock and access historical data on people associated with Truesight Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Truesight Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truesight Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.